Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7576
+0.0075 (1.00%)
At close: Nov 28, 2025, 1:00 PM EST
0.7624
+0.0048 (0.63%)
After-hours: Nov 28, 2025, 4:29 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $39.77 million as of November 28, 2025. Its market cap has decreased by -16.22% in one year.
Market Cap
39.77M
Enterprise Value
-56.73M
1-Year Change
-16.22%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $39.77M, a decrease of -90.68%. That is a compound annual growth rate of -43.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 39.77M | -5.25% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 287.99B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |